Á lódáil...
Variant constraint by mRNA vaccines
The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.
Na minha lista:
| Foilsithe in: | Nat Rev Immunol |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Nature Publishing Group UK
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8034506/ https://ncbi.nlm.nih.gov/pubmed/33837367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-021-00548-5 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|